Ovid Therapeutics Inc. is a biopharmaceutical company dedicated to developing small-molecule medicines for brain conditions with significant unmet need. It is advancing a pipeline of novel, targeted small-molecule candidates that modulate the intrinsic and extrinsic factors involved in neuronal hyperexcitability causative of multiple neurological and neuropsychiatric disorders. It develops OV329, which is a GABA-aminotransferase inhibitor, as a potential therapy for treatment-resistant seizures and other undisclosed indications; OV350, OV4071 and others within a library of compounds that directly activate the KCC2 transporter, for multiple CNS disorders. It also maintains the KCC2 library, which is a portfolio of potential first-in-class direct activators of potassium chloride cotransporter2. Both OV350 and OV4071 are intended for the potential treatment of psychosis associated with neuronal-synuclein diseases (NSD), which include Parkinsonâs disease and Lewy body dementia (LBD).
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļOVID
āļāļ·āđāļāļāļĢāļīāļĐāļąāļOvid Therapeutics Inc
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 05, 2017
āļāļĩāļāļĩāđāļAlexander (Margaret A)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ23
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒOrdinary Share
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļMay 05
āļāļĩāđāļāļĒāļđāđ441 Ninth Avenue, 14Th Floor
āđāļĄāļ·āļāļNEW YORK
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻUnited States of America
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ10001
āđāļāļĢāļĻāļąāļāļāđ12127764381
āđāļ§āđāļāđāļāļāđhttps://ovidrx.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļOVID
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļMay 05, 2017
āļāļĩāļāļĩāđāļAlexander (Margaret A)
iShares Russell 2000 Growth ETF
ProShares UltraPro Russell2000
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proshares Ultra Russell 2000
ProShares Ultra Nasdaq Biotechnology
Invesco Nasdaq Biotechnology ETF
Fidelity Enhanced Small Cap ETF
ProShares Hedge Replication ETF
Avantis Responsible US Equity ETF
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
iShares Russell 2000 Growth ETF
ProShares UltraPro Russell2000
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proshares Ultra Russell 2000
ProShares Ultra Nasdaq Biotechnology
Invesco Nasdaq Biotechnology ETF
Fidelity Enhanced Small Cap ETF
ProShares Hedge Replication ETF
Avantis Responsible US Equity ETF
āļĄāļĩāļāļēāļĢāļāđāļēāļĒāđāļāļīāļāļāļąāļāļāļĨāđāļāđāļāļāļģāļāļ§āļāļĢāļ§āļĄ
0.00
USD āđāļāļāđāļ§āļ 5 āļāļĩāļāļĩāđāļāđāļēāļāļĄāļē

āđāļĄāđāļĄāļĩāļāđāļāļĄāļđāļĨ